LexisNexis® CLE On-Demand features premium content from partners like American Law Institute Continuing Legal Education and Pozner & Dodd. Choose from a broad listing of topics suited for law firms, corporate legal departments, and government entities. Individual courses and subscriptions available.
In a full Tax Court opinion issued on February 2, 2010, the Tax Court found that the petitioner Rhiannon G. O’Donnabhain was entitled to Section 213 medical expenses for the cost of gender reassignment surgery and hormone therapy. O'Donnabhain v. Commissioner, 134 T.C. No. 4 (Feb. 2, 2010) The Court recognized the petitioner's gender identity disorder (GID) diagnosis for IRC Sec. 213 medical expense purposes as a disease. The Court concluded that the hormone therapy and gender reassignment surgery “treated” the disease of GID.
The Court did rule however that Ms. O’Donnabhain was not entitled to that part of the expenses related to *** augmentation as it determined these expenses were cosmetic in nature. The Court found the augmentation surgery excluded from the medical expense deduction because it was cosmetic in nature and did not “meaningfully promote the proper functioning of her body within the meaning of IRC Sec. 213.” It additionally found the surgery not medically necessary.
LEXIS.com users can access the enhanced version of O'Donnabhain v. Comm'r, 2010 U.S. Tax Ct. LEXIS 4 (T.C. Feb. 2, 2010).
If you are not a LEXIS user, you can access Federal Case Law, Codes, Shepard's® Citation, Administrative, Legislative, and Secondary Sources using LexisONE's Research Value Package.